May 2021 - Page 39 of 44

WednesdayMay 05, 2021 1:53 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Nationwide Launch of ‘Perfect On-the-Go Summer Water Choice’

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, today announced the launch of its fully recyclable white aluminum bottle. The product is already being sold in over 2,700 retail locations across the United States. “Loyal consumers are finding more Alkaline88(R) products on the shelves of many of their favorite retailers. The white aluminum single serve is currently being sold in over 2,700 retail locations and through KeHe and UNFI, who service over 50,000 locations,” said Ricky Wright, president and CEO of The Alkaline Water Company. “This is the latest in the continuing SKU…

WednesdayMay 05, 2021 1:38 pm

QualityStocksNewsBreaks – InvestorBrandNetwork Achieves Incredible 2021 Growth Metrics, to Actively Build on Momentum

InvestorBrandNetwork (“IBN”), an innovative corporate communications agency and diversified content distributor, today announced significant growth milestones it has achieved in early 2021. Since the launch of the first brand of its communications platform in 2006, IBN has consistently attained transformative growth. Today, the IBN Investor Brand Platform comprises a portfolio of 50+ brands with a collective social media audience that includes millions of followers and an expansive network of 5,000+ key syndication partners. IBN’s unique value proposition for companies operating across a broad array of industries is demonstrated by its proven track record serving 500+ client partners. “IBN is already…

WednesdayMay 05, 2021 12:56 pm

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Agreement with Renowned Cannabis Farming Company Supports Focus on Genetics

Recent study delving into Canadian cannabis market revealed declining market shares for large Canadian cannabis companies Pac Roots and its peers have looked to increase their share of market, with Pac Roots recently increasing its total area under cultivation Key feature boosting Pac Roots’ prospects has been its focus on producing premium quality strains through meticulous cultivation process A recent study centered around the Canadian cannabis market and carried out by investment banking firm ATB Capital Markets in early April 2021 came up with a startling conclusion: Large Canadian cannabis cultivators had surprisingly seen their market shares decline between the…

WednesdayMay 05, 2021 12:35 pm

Ideanomics Inc. (NASDAQ: IDEX) Should Benefit from Positive Outlooks for Both the EV and Fintech Markets

Projections by various research firms indicate that the electric vehicle (“EV”) and fintech markets will grow through the coming years The EV industry will witness a steady increase in the penetration of EVs in three key markets in which IDEX, through its Ideanomics Mobility division, operates The global fintech industry is projected to grow at a 23.58% CAGR from 2021 to 2025, while the US fintech market is estimated to witness a CAGR of 8.6% from 2019 through to 2024, and the Ideanomics Capital division focuses on fintech solutions A recent electric vehicle (“EV”) market publication by J.P. Morgan (NYSE:…

WednesdayMay 05, 2021 12:33 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Eyes Many Exciting Developments for V2 of Fan Pass Platform

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced growth for its Fan Pass platform for the month of April 2021. Now in testing in version 2 of the Fan Pass live streaming platform, the implementation of new onboarding features and technology upgrades will provide artists with near-instant gratification. The company’s live channel activations increased by 2,250% in the month of April 2021 alone, building on the previous month’s success. “The Fan Pass team is hard at work testing every aspect of our version 2 of the Fan Pass Live platform and I believe our current artists, their…

WednesdayMay 05, 2021 12:29 pm

QualityStocksNewsBreaks – TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Provides Update on Beyond Tobacco(TM) Patent Filing

TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has announced that its Beyond Tobacco(TM) patent filing has advanced to the nonprovisional status. The company submitted the patent filing for its exclusive process that is used to produce Beyond Tobacco’s taste and smell that is similar to tobacco. The filing was submitted to the United States Patent and Trademark Office in September 2020. The patent will protect the refinement technique that characterizes both TAAT(TM) and its Beyond Tobacco base material. The company believes that the patent will prove valuable as the company focuses on establishing a market position and…

WednesdayMay 05, 2021 12:14 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures Centralized IRB Approval for Acclaim-1 Clinical Trial

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced its receipt of centralized Institutional Review Board (“IRB”) approval of the clinical trial protocol for its upcoming Acclaim-1 clinical trial in non-small cell lung cancer (“NSCLC”). Acclaim-1 is an open-label, multi-center Phase 1/2 clinical trial that combines the company’s lead drug candidate, REQORSA(TM) immunogene therapy, with AstraZeneca’s Tagrisso(R) (osimertinib) in patients with late-stage NSCLC with mutated epidermal growth factor receptors (“EGFRs”), whose disease progressed after treatment with Tagrisso. “The purpose of IRB review is to assure that appropriate steps…

WednesdayMay 05, 2021 12:08 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Signs Drug-Development Agreement, One Step Closer to Effective Psychiatric Disorder Treatment

Agreement calls for Cybin, Catalent to work together to develop novel therapy for treatment-resistant psychiatric disorders Cybin looking to identify fast-acting, shorter-duration formulations of CYB003 Delivering CYB003 through Catalent ODT could provide significant benefits Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has inked a drug-development agreement with Catalent Inc. (NYSE: CTLT), a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products (https://ibn.fm/nQdpg). The agreement, which is scheduled to start this month, calls for the two companies to work together to potentially…

WednesdayMay 05, 2021 11:31 am

Current Deficiencies in The Rational Development of CBD-based Wellness Products

Even major players in the CBD market do not offer detailed and verifiable study results to effectively differentiate their products on the basis of meaningful clinical findings, essentially exploiting the “natural” label without any R&D efforts This industry deficiency represents immense opportunities for R&D-driven companies such as Green Hygienics Green Hygienics intends to use its intellectual and capital resources to establish and apply state-of-the-art research and development to a new generation of cannabinoid-based products having specifically assessed health-wellness efficacies CBD Reality Check Interest in the therapeutic use of hemp-derived nonintoxicating cannabinoids, such as cannabidiol (“CBD”) and cannabigerol (“CBG”), has reached…

WednesdayMay 05, 2021 10:25 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) Rail Vision Enters Agreement to Supply Proof-of-Concept Prototype

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its affiliate, Rail Vision Ltd., has entered an agreement with Hitachi Rail STS Australia Pty Ltd. to supply equipment, services and personnel to the Australian rail company Rio Tinto Railway Network. Under the agreement, Hitachi Rail STS, the project integrator, will provide Rio Tinto with a prototype of Rail Vision’s Collision Avoidance System to undergo demonstration and feasibility testing for a proof-of-concept project. Project revenue is expected to total $265,000, with an option for Rail Vision to furnish additional services for $133,000. To view…

Site Search

Company Search

Month: May 2021